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1. Introduction
Glaucoma derives from an increase of the intra-ocular pressure (IOP) due to accumulation of
the aqueous humor which causes degenerative events at the level of the retina and the optic
nerve. This results in a progressive damage of the optic nerve that is paralleled by the gradual
loss of retinal ganglion cells (RGC). The pathology causes increasing eyesight deterioration
particularly in the peripheral areas of the visual field. The optic nerve papilla becomes paler
and shows an augmented excavation as compared with a normal physiological situation. The
increase of the IOP is to be ascribed, in the majority of cases, to an alteration of the ocular
hydrodynamics: in particular the normal efflux of aqueous humor from the anterior chamber
of the eye is severely hindered. The drainage system is located in the limbal regions or in the
sclero-corneal junction. The inner surface presents a hollow (depression) known as inner
scleral spur which is filled by the trabecular meshwork and the canal of Schlemm. Primary
open angle glaucoma is caused by the failure of drainage from the trabecular meshwork, while
the primary closed angle glaucoma consists in a modification of the iris-corneal angle. It is
commonly accepted that glaucoma is the second cause of blindness in the world; as a matter
of fact it has been estimated that 68 millions of patients are affected by this pathology and out
of them, about 7 millions suffer complete bilateral blindness as a consequence of the glaucoma.
The onset of the disease may occur at any age, also at childhood, but it is significantly more
frequent in elderly people. Glaucoma is generally categorized in five different groups; two of
them are the above mentioned open and closed angle primary glaucoma which are also the
most widespread ones. A broad variety of pathological conditions may induce, as secondary
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event, the obstruction of the drainage system of the drainage angle which results in glaucoma.
The primary open angle, which represents more than 60% of the cases, is a chronic condition.
The outflow angle is not altered; the aqueous humor produced by the ciliary body reaches the
trabecular meshwork, but its drainage is not efficient. This is possibly due to the decrease of
diffusion towards the Schlemm’s canal which causes a continuing increase of the IOP ending
in the progressive degeneration of the optic nerve. Among the secondary factors contributing
to the insurgence of glaucoma one should take into account: age (above 70), myopia and ethnic
origin since the African populations seem to be more prone to develop the disease.
In the primary closed angle glaucoma which occurs in about 10% of patients, a closure of the
filtration angle in the eye is observed and this is occasionally due to the trabecular obstruction
by the iris. The mode of insurgence of this type of glaucoma, unlike other forms, is very rapid
and is therefore also known as acute glaucoma. In this condition one of the main risk factors
is also associated to familial and/or ethnic factors. As a matter of fact, East asian populations,
the Chinese one in particular, show a significant aptitude towards this pathology, other risk
factors being the patient’s age (above 50 years of age the incidence of the pathology increases)
and hypermetropia. To date a decisive therapy for neither open nor closed angle glaucoma is
available, however some treatments exist allowing the slowing, and in some cases the arrest,
of the progression of the disease.
Secondary glaucoma may develop as a consequence of other pathologies such as inflammation,
cataract, traumas, pigments released from the iris and, finally, tumors. In this situation the eye
activates its defense producing the hyper-secretion of aqueous humor thus leading to ocular
hypertension. One of the main characteristics of glaucoma is the increased excavation of the
optic disk which extends towards its margins. Even though some studies support the idea that
the pathology may start at retinal level, some indications exist that the early lesions occur at
the level of the head of the optic nerve, in particular on the lamina cribrosa. Investigations
demonstrate that the death of RGC occurs by apoptosis [1, 2]; the activation of this process,
most likely, causes a reduction of the number of axons forming the optic nerve and this would
evolve to the clinical signs consisting in the characteristic increase of papilla excavation which
results in a reduction of the optic visual field. The ganglion retinal cells are the first target of
the damage, mainly those found in the temporal region of the retina where the lamina cribro‐
sa is thinner and thus gives an inefficient structural support to the RGC axons [3].
Hypotheses on the mechanisms of cell degeneration are diverse, the mechanical stress and the
ischemic model being two of the most corroborated ones. The mechanical stress theory
purports that the increase of the IOP within the anterior chamber causes a direct hyper-
pressure at the retina-vitreous interface. This mechanical stress would directly trigger cell
death by physical compression. According to this theory the mechanical insult causes modi‐
fications of the cell function: with respect to this, it has been reported that this type of insult
may alter gene expression in organs such as the heart and the endothelial vessels. Furthermore,
by the activation of transduction pathways, different functional responses are induced in
retinal cells and astrocytes [4]. This IOP-induced mechanical stress could also inhibit the
retrograde transport along the ganglion cell axons. Regarding this particular point, it has been
observed a block in the axonal transport at the level of the lamina cribrosa followed by a drastic
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reduction of neurotrophins required for the survival of the RGC [5]. Furthermore, a reduction
of the axon-plasma transport and the accumulation of toxic level of neurotransmitters have
been observed; also, an increase of nitric oxide and endothelins as well as remodeling of the
extra-cellular matrix has been monitored. Studies validate, on the other hand, the theory of the
ischemic model, i,e, the vascular model of ischemia, as a main cause of the increased mechanical
compression and subsequent oxidative stress at cell level.
The ischemic hypothesis postulates that the high intraocular pressure and the deformation of
the lamina cribrosa may generate a compression of the blood vessels at retina and/or optic nerve
level with a subsequent ischemic damage. In the pathological ischemic condition a temporary
interruption of blood perfusion occurs and this determines a lack of oxygen, glucose and
trophic substances in general. In patients with normal pressure and open angle glaucoma it
was reported a decrease of the blood flow at the head of the optic nerve and an increase of
hemagglutination. In addition, in this type of glaucoma an alteration of endothelin-mediated
blood flow occurs. This protein is expressed in the endothelial cells and constricts blood vessels
thus raising the blood pressure; its action is mainly exerted on the smooth muscles of the blood
vessels [6]. The raise of the IOP plays a crucial role in the etiology of the disease, however the
observation of glaucoma patients with normal pressure values suggests that diverse factors
act synergistically to the insurgence of the pathology.
The glaucoma neuropathy may be also due to an insufficient vascular perfusion of the optic
nerve which causes an ischemic damage to this organ. The ischemia thus generated, ends in
an oxidative stress at RGC level and causes apoptotic death. This phenomenon happens
because when re-perfusion initiates, the presence of oxygen in the tissue exposed to ischemia,
induces the formation of radical oxygen species (ROS). When the concentration of ROS is too
high, the anti-oxidant systems of the cell become unable to inactivate them, due to a deficient
homeostasis, thus the free radicals are no longer neutralized and may cause cell death either
via apoptosis or necrosis. In conclusion both types of stress, the mechanical and the ischemic
one, can contribute to the establishment of the disease [2].
1.1. Cellular targets of the ocular hypertension
A complex interaction between neural and glial cells exists during the differentiation and the
life of the nervous system. As a matter of fact, neuroglia cells maintain the normal functions
of the nervous system since they control the extra cellular environment, block the toxic agents
and supply the trophic resources and, last but not least, provide a structural support to the
neurons. In glaucoma, astrocytes play a very important role as far as the re-modeling of the
lamina cribrosa is concerning. Actually, they may also have a role also in the onset of the disease.
Studies conducted on human glaucoma have, in fact, evidenced that the disorganization at
astrocyte level in the anterior areas of the optic nerve, is associated to hypertrophy and over-
expression of the glial fibrillary acidic protein (GFAP) which also occurs in astrocyte cultures
subjected to high hydrostatic pressure. Following ischemic episodes, traumas or neuro-
degenerative disorders, the phenotype of the astrocyte cells and microglia, activates the
production of cytokines, ROS, nitric oxide and tumor necrosis factor α (TNF-α); all these
molecules are mediators involved in the tissue damage [2]. In a similar way, glial cells located
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in the retina and in the head of the optic nerve may carry out their normal physiological role
as supporters of the cell bodies and their relative axons of the ganglion cells; on the contrary
they may have a noxious role towards the same structures in pathological conditions.
1.2. Oxidative stress and retinal ganglion cell death in glaucoma
Oxidative stress is initiated by the imbalance between the production of ROS and their
elimination by antioxidants. This phenomenon plays a key role in neuronal damage ending
with neuron death which usually occurs by apoptosis. These reactive oxygen species are
produced by mitochondria but can also derive from enzymatic degradation of neurotrans‐
mitters, neuroinflammatory mediators, and redox reactions [7]. Mitochondrial dysfunction
can result in an increased level of ROS which is often found in neurodegenerative pathologies.
Abnormal protein folding, defective ubiquitination and proteasome degradation systems may
cause the production of ROS [8]. This promotes neuronal death via diverse molecular mecha‐
nisms including protein modification and DNA damage [9]. In any case, whether the oxidative
stress triggers cell death is a component of a more complex neuro-degenerative process is yet
to be elucidated [8]. Literature reports exist showing that neural damage occurs following
oxidative stress in animal models of optic nerve injury and in human glaucoma. For example,
DNA damage as well as protein and lipid peroxidation products, such as malonal-dihaldehyde
accumulate in the trabecular meshwork and retina in animals with raised IOP [2, 10 - 16]. The
high concentration of intra-cellular ROS has also been proposed as a crucial death signal after
axonal injury, even though this may not directly cause a glaucoma, which would lead to RGC
apoptosis [17 – 21]. Dysfunction of perfusion and reduced oxygen availability may play a role
in the insurgence of an oxidative damage [22, 23]. The formation of ROS at mitochondrion level
is required to activate a transcription factor known as hypoxia-inducible factor-1 alpha that
induces the expression of several genes involved in the control of hypoxia, [24, 25]. Cells have
a very effective protective antioxidant system including superoxide dismutase (SOD), catalase,
glutathione peroxidase and glutathione reductase [26]; if this systems partially or totally fail
in neutralizing the ROS in the RGCs population, the progression of glaucoma could be
triggered. Evidence exists supporting this idea; as a matter of fact SOD activity is lower than
normal in the trabecular meshwork of glaucoma patients [27, 28] and in the retina as monitored
in experimental ocular model of hypertension [19]. A recent study in vivo showed a dramatic
increase in RGCs after optic nerve axotomy which preceded apoptosis [19]. Reactive oxygen
species alter the redox equilibrium in the cell and this produces cysteine sulfhydryl oxidation.
As a consequence oxidative cross-linking leads to the formation of new disulfide bonds that
result in conformational changes of the proteins and activation of apoptotic signals [29, 30]. To
date many studies have shed light on the molecular events causing the death of RGC. These
evidences were gathered from investigations on animal models where acute or chronic optic
nerve damage was generated and in experimentally induced glaucoma. A number of cellular
phenomena are involved in the apoptotic death of RGCs; just to mention some: deprivation of
neurotrophic factor, loss of synaptic connectivity, oxidative stress, axonal transport failure (for
an exhaustive review on this topics see [31]).
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Apart from the elevated intraocular pressure, other risk factors such as genetic background,
decreased corneal thickness, age and vascular dys-regulation may play an important role in
the insurgence of glaucoma [32 - 39]. However, even if these factors may determine a risk to
develop the disease, it remains difficult to establish a cause/effect relationship to develop this
pathology: actually, one should consider that a high intraocular pressure is common among
open-angle patients but many individuals showing this sign eventually will not develop
glaucoma [40]. A further apparently paradoxical phenomenon is that a significant number of
glaucoma patients progressively lose vision even though they react positively to drugs
lowering the IOP [41 - 44]. In conclusion the cause of RGC in glaucoma still remains to be fully
elucidated. Certainly the understanding of the apoptic death in RGC determined by the
pathology is to be ascribed to the high complexity and the multifactorial character of the
disease. The development of new neuroprotective therapies, even though will give a scant
contribution to the elucidation of the molecular and cellular mechanisms underlying the
disease, will certainly help to slow the development and progression of the pathology in
glaucoma patients.
1.3. Mitochondrial malfunctions and ophthalmogical diseases
The association of ophthalmologic diseases to a mitochondrial etiology is assuming an
increasingly interest: many authors consider, as a matter of fact, that the pathologies originate
from impaired mitochondrial function, oxidative stress and enhanced apoptotic death. The
mitochondrial role in the development of primary congenital glaucoma, characterized by
trabecular dysgenesis, has been recently suggested. The formation of the trabecular meshwork
during development is thought to have particular sensitivity to oxidative stress induced
damage. Mitochondrial DNA (mtDNA) mutations, in particular, are emerging as causative
agents of ophthalmologic disorders affecting mostly the optic nerve and the retina as well as
the extra-ocular muscles. Also in these cases antioxidant therapy represents a good tool to treat
these ophthalmologic conditions. Mitochondrial dysfunction is suggested, for example, to play
an important role in age related macular degeneration, glaucoma and diabetes dependant
retinopathy. Some biomarkers have been identified in the mitochondrial oxidative stress
response: for instance, prohibitins also known as PHB may have diverse functions and are also
involved in mitochondrial structure and functionality. These proteins present a ring-like
structure with 16–20 alternating Phb1 and Phb2 subunits in the inner mitochondrial membrane
[45]. The precise molecular function of the PHB molecular complex is not clear even though it
has been hypothesized that they may have a role as chaperone for respiration chain proteins
or as providers of a scaffold for the optimal mitochondrial morphology and function. Prohib‐
itins have been demonstrated to stimulate cell proliferation both in plants and mammals such
as rodents. As far as tissue re-modeling is concerned, the proteins of the matrix metallopro‐
teinase (MMP) family could be a useful tool in gene therapy aimed at the protection/rescue of
the RGCs. Therefore PHB and MMP could constitute an effective biomarker and/or a thera‐
peutic target for ophthalmologic pathologies. (For a recent review see [46]).
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2. A model of experimental glaucoma in rat
Several experimental animal models exist to investigate the ocular pathologies. In our
laboratory we have developed a rat model of hypertension that mimics and reproduces the
situation found in human glaucoma. This animal model will be briefly reviewed in the
following sections [2].
2.1. Induction of the intra-ocular hypertension
To induce ocular hypertension in vivo [50] causing a condition of acute glaucoma in rat we
injected in the anterior chamber of the right eye methylcellulose (MTC) suspended in physio‐
logical solution (the contra-lateral eye served as control). The IOP was monitored by tonom‐
etry. The hypertension induced by MTC was also performed in the presence of the antioxidant
trolox [50]. The degree of animal sufferance was evaluated by the behavioral Irwin test and by
the recovery of bodyweight. Ocular inflammation was assessed by the Drize test adapted to
the rat, both approaches were described in detail in [49]. Intra-ocular pressure was monitored
on 20 different animals that were finally sacrificed by hemorrhagic shock (decapitation). The
eyes were removed and the cornea eliminated at limbus level; vitreous humor, and crystalline
lens were discarded. The remaining samples of retina and optic nerve were fixed in para-
formaldehyde, quickly washed in PBS finally included in freezing resin and cryostat-cut.
Chromatin morphology and structure as well as DNA fragmentation was evidenced by
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) reaction and validat‐
ed by the formation of the apoptotic ladder after agarose gel electrophoresis. The apoptotic
ladder is generated by nucleolytic inter-nucleosomal DNA cleavage since during the late stages
of apoptosis the enzyme DNase I is activated. This causes the formation of multiple nucleo‐
somal DNA fragments which can be easily visualized, by gel electrophoresis, by fluorescence
after ethidium bromide staining.
2.2. Lipoperoxidative damage of the membrane and apoptosis after induction of cell stress
The data obtained in our laboratory support the idea that ocular hypertension causes apoptotic
death of retinal ganglion cells and over-expression of molecular markers typical of oxidative
cell stress response and apoptosis. Glial cells may have a neuroprotective role in a pathological
situation; in any case they may contribute protection from neuron damage. In particular,
during progression of glaucoma, astrocytes are involved in the re-modeling of the lamina
cribrosa and they could act as initiators of the pathology. With respect to this see the role of
PHB and MMP mentioned in preceding section. Studies on experimental models of ocular
hypertension and human glaucoma evidenced an astrocyte hypertrophy and a loss of organ‐
ization both at retina and optic nerve level. The up-regulation of the GFAP was also observed,
as mentioned in a previous section of this work, in cultured astrocytes grown at high hydro‐
static pressure. The GFAP is considered a very important stress marker in diverse retinal
pathologies. Activation of the glial cells may also have noxious consequences on neurons, as
they may cause mechanical damages and alterations of the micro-enviroment also, they may
fail to provide the structural/nutritionl support to the neural cells. This could trigger the release
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and/or production of neurotoxic and proapoptotic compounds such as nitric oxide synthase
(NOS). The nitric oxide thus produced is a reactive free radical present in cells as a response
to increased intracellular concentrations of Ca2+. It is known that NOS increases in cerebral
ischemia and the over-expression of this enzyme causes relevant damage: the overall result is
a detrimental action on the cell membrane. Recent studies demonstrated that an excess of NO
is toxic and this compound increases as a consequence of ocular hypertension. In glaucoma,
the involvement of inducible NOS (iNOS) has also been suggested. The oxidative stress and
the increase of IOP also cause up-regulation of ubiquitin (Ub) and stimulation of the Ub-
proteasome pathway: this possibly derives from the activation of the apoptotic program. In
any case it should be pointed out that we also demonstrated that a well-known natural
substance, carnitine, endowed of antioxidant properties and improvement of muscle perform‐
ance, can ameliorate the glaucomatous pathology in the rat model system developed in our
laboratory [2, 16].
3. Conclusions
In conclusion, literature data imply that the RGCs are one of the main targets of the oxidative
stress in the neural tissue. As shown in our studies, the injection of methylcellulose into the
anterior chamber of the eye activates diverse signals of stress at the level of RGCs. Mainly, the
up-regulation of the GFAP and DNA damage become evident. Methylcellulose hinders the
efflux of fluids from the canals of Schlemm thus increasing the IOP. The consequent oxidative
stress is shown by the overexpression of iNOS, which is an enzyme primarily involved in the
mitochondrial lipid peroxidation, with consequent damage of the cell membrane. This is
validated by the accumulation of intracellular malonal-dihaldehyde: a hallmark of lipoperox‐
idation. The ubiquitin-mediated proteasome pathway is also activated and this is directly
related to the execution of the apoptotic death. The antiapoptotic role of carnitine plays a key
role in the stabilization and function of the cell membrane, the mitochondrial one in particular.
The contemporary treatment with methylcellulose and carnitine reduces the level of typical
markers of cell sufferance and apoptotis, this enhances the mitochondrial performance,
improves the overall homeostatic response to the hypertensive insult, and limits the apoptotic
phenomena.
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